Craft

Kailera Therapeutics

Kailera Therapeutics Summary

Company Summary

Overview
Kailera Therapeutics is a company that develops injectable and oral therapies for the treatment of obesity. It offers injectable and oral peptides, as well as oral small molecules.
Type
Public
Status
Active
Founded
2024
HQ
Waltham, MA, US | view all locations
Website
https://www.kailera.com
Cybersecurity rating
Sectors

Key People

  • Ron Renaud, President & Chief Executive Officer

    LocationsView all

    1 location detected

    • Waltham, MA HQ

      United States

      180 3rd Ave 4th floor

    Kailera Therapeutics Financials

    Summary Financials

    Net income (Q1, 2026)
    ($78.9M)
    Cash (Q1, 2026)
    $111.8M
    EBIT (Q1, 2026)
    ($84.7M)

    Footer menu